The Effect of a Pre-meal Snack and/or Exercise on Post-prandial Glycemic Excursions in Adults With Cystic Fibrosis
SNACK_CF
1 other identifier
interventional
14
1 country
1
Brief Summary
The investigators aim to test the feasibility and effectiveness of a pre-meal snack to reduce the postprandial glycemia (PPG) excursion after a breakfast consumption in adult patients with cystic fibrosis (CF). The investigators also want to investigate the impact of a postprandial exercise to reduce the PPG excursion. An improvement in PPG excursions can improve the condition of CF patients primarily by delaying the onset of cystic fibrosis related diabetes (CFRD) and / or by reducing the risk of lung function loss.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2018
CompletedFirst Posted
Study publicly available on registry
October 18, 2018
CompletedStudy Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 26, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedApril 25, 2023
April 1, 2023
3.2 years
June 20, 2018
April 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total area under the curve for plasma glucose
Overall study period (4 hours)
Secondary Outcomes (12)
Area under the curve for plasma glucose
From start of study to breakfast time (1 hour)
Area under the curve for plasma glucose
From time of breakfast to the end of the study (3 hours)
Total area under the curve for insulin
Overall study period (4 hours)
Area under the curve for insulin
From start of study to breakfast time (1 hour)
Area under the curve for insulin
From breakfast time to the end of the study (3 hours)
- +7 more secondary outcomes
Study Arms (4)
[Placebo + Sedentary]
NO INTERVENTION1\) Consumption of 200ml of water (flavored) + breakfast of 90g of carbohydrates (CHO) for men and 80g for women; Sedentary activities throughout the study
[Snack effect + Sedentary]
EXPERIMENTAL2\) Consumption of 200ml of soy beverage + 90g of carbohydrate (CHO) breakfast for men and 80g for women; Sedentary activities throughout the study
[Placebo + Exercise]
EXPERIMENTAL3\) Consumption of 200ml of water (flavored) + breakfast of 90g of carbohydrates (CHO) for men and 80g for women + physical activity practice (3min walk at 60% VO2max every 30 minutes, x5);
[Snack + Exercise]
EXPERIMENTAL4\) Consumption of 200ml of soy beverage + breakfast of 90g of carbohydrate (CHO) breakfast for men and 80g for women + physical activity practice (3min walk at 60% VO2max every 30 minutes, x5).
Interventions
Consumption of a 200ml of soy beverage (100Kcal, 11g CHO, 6g proteins, 4g fat)
3min walk at 60% VO2max every 30 minutes,(x5)
Eligibility Criteria
You may qualify if:
- Diagnosis of cystic fibrosis,
- Be over 18 years old.
You may not qualify if:
- Pharmacological treatment for cystic fibrosis related diabetes.
- Signs of secondary infection: the test will be practiced at least 1 month after the end of infection treatment
- People with severe gastrointestinal illness (Crohn's disease, celiac disease and a recent history (\<1 year) of bowel obstruction).
- Allergy to one of the ingredients of the menu (example: celiac disease)
- According to the judgment of the investigator, medications or conditions that could interfere with glucose metabolism (eg: oral steroids)
- Pregnancy in progress
- Corrector or potentiator prescribed whose dose is not stable the last 2 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut de Recherches Cliniques de Montréal (IRCM)
Montreal, Quebec, H2W 1R7, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rémi Rabasa-Lhoret, MD, PhD
IRCM
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- snack beverage or flavored placebo will be not recognizable
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2018
First Posted
October 18, 2018
Study Start
April 1, 2019
Primary Completion
May 26, 2022
Study Completion
December 31, 2022
Last Updated
April 25, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share